At the end of Q2 2025, 28 institutions reported holding Sinovac Biotech Ltd. (SVA) in their 13F filings, up 25 from Q1 2025. 26 opened new positions and 0 sold out. The largest holders were Orbimed Advisors LLC ($334.0M), Vivo Capital, LLC ($38.2M) and Neumann Advisory Hong Kong Ltd ($2.0M). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
Company
Sinovac Biotech Ltd.
CUSIP
P8696W104
Latest filing quarter
Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
Institutions
Total Value
New Positions
26
$39.3M
Exits
0
$0
All 13F filers, Q1 2025 → Q2 2025: 7,451,213 shares bought, net +7,451,213 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.